US Pharm. 2012;37(4):1.
Arlington, VA—The Infectious Diseases Society of
America (IDSA) has issued new guidelines regarding the treatment of
sinus infections. An estimated 98% of cases are caused by viruses,
rather than bacteria, and should not be treated with antibiotics—a
common practice that contributes to drug resistance. With no test to
easily determine the source of infection, many physicians prescribe
antibiotics as a precaution. If symptoms do not improve after 10 days
and include fever of 102º F or higher, nasal discharge, or facial pain,
the infection is likely bacterial and should be treated with
antibiotics. For bacterial infections, the IDSA recommends a shorter
course of treatment of 5 to 7 days with amoxicillin-clavulanate, an
antibiotic combination that helps to overcome resistance.
To comment on this article, contact firstname.lastname@example.org.
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.